Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 34

Sort by

Sort Order Select

Journal Articles

Correlation between Peak Absolute Lymphocyte Count Post Brexucabtagene Autoleucel Infusion and Outcomes in Mantle Cell Lymphoma

Blood (2024) 144 (Supplement 1): 1651.

https://doi.org/10.1182/blood-2024-200408

Published: 2024

Journal Articles

Autologous Stem Cell Transplant in Fit Patients with Late Relapsed Diffuse Large B-Cell Lymphoma That Responded to Salvage Chemotherapy

Aung M. Tun, Seth Maliske, Yucai Wang, David James Inwards, Thomas M. Habermann, Ivana Micallef, Luis Porrata, Jonas Paludo, J. C. Villasboas, Allison C. Rosenthal, Mohamed A. Kharfan-Dabaja, Stephen M Ansell, Grzegorz S. Nowakowski, Umar Farooq, Patrick B Johnston

Blood (2023) 142 (Supplement 1): 2216.

https://doi.org/10.1182/blood-2023-185002

Published: 2023

Journal Articles

Outcomes in Mantle Cell Lymphoma with Central Nervous System Involvement - a Dual Center Study

Blood (2023) 142 (Supplement 1): 1670.

https://doi.org/10.1182/blood-2023-174701

Published: 2023

Journal Articles

Comparison of Methotrexate Maintenance Versus Autologous Stem Cell Transplant Consolidation after High-Dose Methotrexate-Based Induction Therapy in Primary Central Nervous System Lymphoma

Steven R Hwang, Patrick B Johnston, Richard C. Godby, Brianna Gysbers, Raphael Mwangi, Ivana Micallef, Stephen M Ansell, Luis Porrata, Urshila Durani, Gita Thanarajasingam, Matthew J. Maurer, Thomas M. Habermann, Arushi Khurana

Blood (2023) 142 (Supplement 1): 989.

https://doi.org/10.1182/blood-2023-178081

Published: 2023

Journal Articles

Day 100 Inhibitory KIR2DL2 and Activating NKp30 Natural Killer Cell Receptors Predicts Survival Post-Autologous Stem Cell Transplantation in Lymphomas

Luis Porrata, Stephen M Ansell, Ivana Micallef, Patrick B Johnston, J. C. C Villasboas, Jonas Paludo, Urshila Durani, Svetomir Markovic

Blood (2023) 142 (Supplement 1): 4967.

https://doi.org/10.1182/blood-2023-173453

Published: 2023

Journal Articles

Central Nervous System Involvement in Peripheral T-Cell Lymphoma

Sangeetha Gandhi, MBBS, N. Nora Bennani, MD, Sonia Fortin, Thomas M. Habermann, MD, Patrick Johnston, MD, James R. Cerhan, MD PhD, Kay M. Ristow, BS, Carrie A. Thompson, MD, Grzegorz Nowakowski, MD, Yi Lin, MD PhD, Jose C Villasboas, MD, Luis Porrata, MD, Thomas E. Witzig, MD, Ivana Micallef, MD, David J Inwards, MD, Stephen M Ansell, MD PhD, Jonas Paludo, MD

Blood (2019) 134 (Supplement_1): 5293.

https://doi.org/10.1182/blood-2019-131965

Published: 2019

Journal Articles

Event-Free Survival at 24 Months Following Autologous Stem Cell Transplant in Diffuse Large B-Cell Lymphoma

Seth M Maliske, MD, Matthew J. Maurer, MS, Carrie A. Thompson, MD, Luis Porrata, MD, Ivana Micallef, MD, Rebecca L. King, MD, Sergei Syrbu, MD PhD, Brian K. Link, MD, Margarida Magalhaes Silverman, MD, Yogesh Jethava, MBBS,MDFRCPath,MRCP, David James J Inwards, MD, Stephen M Ansell, MD PhD, James R. Cerhan, MD PhD, Patrick Johnston, MD PhD, Umar Farooq, MD

Blood (2019) 134 (Supplement_1): 2896.

https://doi.org/10.1182/blood-2019-124579

Published: 2019

Journal Articles

Short Time between Progression after Immunochemotherapy and Initiation of Salvage Therapy (PTI) Is Associated with Inferior Long-Term Outcomes in Patients with Relapsed/Refractory DLBCL

Matthew J. Maurer, MS, Umar Farooq, MD, Madison M Wahlen, Thomas M. Habermann, MD, Gita Thanarajasingam, MD, Sergei Syrbu, MD PhD, William R. Macon, MD, Patrick Johnston, MD, Ivana Micallef, MD, Luis Porrata, MD, Susan L. Slager, PhD, Stephen M. Ansell, MD PhD, Thomas E. Witzig, MD, James R. Cerhan, MD PhD, Grzegorz S. Nowakowski, MD, Carrie A. Thompson, MD, Brian K. Link, MD

Blood (2018) 132 (Supplement 1): 4204.

https://doi.org/10.1182/blood-2018-99-114331

Published: 2018

Journal Articles

Lenalidomide in Combination with Standard R-CHOP Overcomes the Negative Prognostic Value of Peripheral Blood Absolute Lymphocyte/Monocyte Ratio at Diagnosis and during Treatment in Patients with Diffuse Large B-Cell Lymphoma

Alessia Castellino, MD, Levy D. Pederson, Kay M. Ristow, BS, Christina Stenzel, Betsy Laplant, MS, Thomas E. Witzig, MD, Thomas M. Habermann, MD, Grzegorz S. Nowakowski, MD, Luis Porrata, MD

Blood (2018) 132 (Supplement 1): 4139.

https://doi.org/10.1182/blood-2018-99-114010

Published: 2018

Journal Articles

Infusion of NKp30/KIR2DL2 Natural Killer Cell Ratio and Survival Post-Autologous Stem Cell Transplantation in Lymphomas

Luis Porrata, MD, David J Inwards, MD, Stephen M. Ansell, MD PhD, Ivana N Micallef, MD, Patrick Johnston, Jose C Villasboas, William J. Hogan, MBBCh, Svetomir Markovic, MD PhD

Blood (2018) 132 (Supplement 1): 3430.

https://doi.org/10.1182/blood-2018-99-109922

Published: 2018

Journal Articles

Impact of MYD88 L265P mutation Status on Histological Transformation of Waldenstrom Macroglobulinemia

Blood (2018) 132 (Supplement 1): 2884.

https://doi.org/10.1182/blood-2018-99-120046

Published: 2018

Journal Articles

Autologous Stem Cell Transplantation for Mantle Cell Lymphoma in the Elderly (≥65 Years Of Age): The Mayo Clinic Experience

Priyanka Pophali, MD, Allison C. Rosenthal, DO, Han Tun, MD, Craig B. Reeder, MD, Ivana N Micallef, MD, Luis Porrata, MD, Stephen M Ansell, MD PhD, Patrick Johnston, MD, David J Inwards, MD

Blood (2017) 130 (Supplement 1): 4536.

https://doi.org/10.1182/blood.V130.Suppl_1.4536.4536

Published: 2017

Journal Articles

Baseline Immune Dysregulation in Autologous Stem Cell Transplant Recipients Is Associated with a 'Graft Versus Host'-like Syndrome and Results in Poor Outcomes

Theodora Anagnostou, MD, Mrinal M. Patnaik, MDMBBS, Cynthia L Forsman, PhD, Reona Sakemura, MD PhD, Mark R. Litzow, MD, Dennis A. Gastineau, MD, Francis K Buadi, MD, Luis Porrata, MD, Julia S Lehman, MD, William J. Hogan, MBBCh, Shahrukh K. Hashmi, MDMPH, Saad Sirop Kenderian, MD

Blood (2017) 130 (Supplement 1): 4550.

https://doi.org/10.1182/blood.V130.Suppl_1.4550.4550

Published: 2017

Journal Articles

PD-1 Blockade with Pembrolizumab in Relapsed Low Grade Non-Hodgkin Lymphoma

Blood (2017) 130 (Supplement 1): 4055.

https://doi.org/10.1182/blood.V130.Suppl_1.4055.4055

Published: 2017

Journal Articles

Outcomes of DLBCL Patients Entering Surveillance (without maintenance) after Immunochemotherapy in a Large Observational Study

Grzegorz S. Nowakowski, MD, Matthew J Maurer, MS, Carrie A Thompson, MD, William R. Macon, MD, Susannah Howlett, Thomas M. Habermann, MD, Umar Farooq, MD, Luis Porrata, MD, Sergei Syrbu, MD, Stephen Ansell, MD PhD, Thomas E. Witzig, MD, James R Cerhan, MD PhD, Brian K Link, MD

Blood (2016) 128 (22): 3036.

https://doi.org/10.1182/blood.V128.22.3036.3036

Published: 2016

Journal Articles

Treatment and Clinical Outcomes of High Grade B-Cell Lymphomas with MYC and BCL2 and/or BCL6 Rearrangements (Double Hit/Triple Hit Lymphomas)

Thomas M. Habermann, MD, William R. Macon, MD, Matthew J Maurer, MS, Rhett P. Ketterling, MD, Paul J Kurtin, MD, Andrew L Feldman, MD, Rakhee Vaidya, MD, James R Cerhan, MD PhD, Stephen Ansell, MD PhD, Luis Porrata, MD, Grzegorz S. Nowakowski, MD, Thomas E. Witzig, MD, Ellen D. McPhail, MD

Blood (2016) 128 (22): 155.

https://doi.org/10.1182/blood.V128.22.155.155

Published: 2016

Journal Articles

Subnormal Lymphocyte Count Predicts Inferior Survival in Myelodysplastic Syndromes: A Single Center Experience in 889 Patients

Lyla Saeed, MBBS, Mrinal M Patnaik, MBBS, Kebede H. Begna, MD, Aref Al-Kali, MD, Curtis A. Hanson, MD, Mark R Litzow, MD, Rhett P. Ketterling, MD, Luis Porrata, MD, Animesh Pardanani, MBBS, PhD, Naseema Gangat, MBBS, Ayalew Tefferi, MD

Blood (2016) 128 (22): 5534.

https://doi.org/10.1182/blood.V128.22.5534.5534

Published: 2016

Journal Articles

Sustained Natural Killer Cell Recovery Post-Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation Predicts Survival in Non-Hodgkin's Lymphoma

Luis Porrata, MD, David James Inwards, MD, Stephen M Ansell, MD, PhD, Ivana Micallef, MD, Patrick B. Johnston, MD PhD, Wendy Nevala, Svetomir Markovic, MD PhD

Blood (2016) 128 (22): 4641.

https://doi.org/10.1182/blood.V128.22.4641.4641

Published: 2016

Journal Articles

Treatment Patterns and Outcomes of DLBCL after Failure of Front-Line Immunochemotherapy

Umar Farooq, MD, Matthew J Maurer, MS, Stephen M Ansell, MD, PhD, Tasha Lin, MD, Grzegorz S. Nowakowski, MD, Luis Porrata, MD, David J. Inwards, MD, William Macon, MD, Syrbu Sergei, MD, James Cerhan, MD PhD, Thomas E. Witzig, MD, Brian K Link, MD, Thomas M. Habermann, MD, Carrie A. Thompson, MD

Blood (2015) 126 (23): 2683.

https://doi.org/10.1182/blood.V126.23.2683.2683

Published: 2015

Journal Articles

Lymphocyte-to-Monocyte Ratio at Diagnosis and Survival in De Novo Double/Triple Hit Diffuse Large B-Cell Lymphoma

Luis Porrata, MD, Kay Ristow, Ellen D. McPhail, MD, William Macon, MD, Matthew J Maurer, MS, Grzegorz S. Nowakowski, MD, Stephen Ansell, MD PhD, Thomas E. Witzig, MD, Svetomir Markovic, MD PhD, Thomas M. Habermann, MD

Blood (2015) 126 (23): 3885.

https://doi.org/10.1182/blood.V126.23.3885.3885

Published: 2015

NARROW

Correlation between Peak Absolute Lymphocyte Count Post Brexucabtagene Autoleucel Infusion and Outcomes in Mantle Cell Lymphoma

Autologous Stem Cell Transplant in Fit Patients with Late Relapsed Diffuse Large B-Cell Lymphoma That Responded to Salvage Chemotherapy

Outcomes in Mantle Cell Lymphoma with Central Nervous System Involvement - a Dual Center Study

Comparison of Methotrexate Maintenance Versus Autologous Stem Cell Transplant Consolidation after High-Dose Methotrexate-Based Induction Therapy in Primary Central Nervous System Lymphoma

Day 100 Inhibitory KIR2DL2 and Activating NKp30 Natural Killer Cell Receptors Predicts Survival Post-Autologous Stem Cell Transplantation in Lymphomas

Central Nervous System Involvement in Peripheral T-Cell Lymphoma

Event-Free Survival at 24 Months Following Autologous Stem Cell Transplant in Diffuse Large B-Cell Lymphoma

Short Time between Progression after Immunochemotherapy and Initiation of Salvage Therapy (PTI) Is Associated with Inferior Long-Term Outcomes in Patients with Relapsed/Refractory DLBCL

Lenalidomide in Combination with Standard R-CHOP Overcomes the Negative Prognostic Value of Peripheral Blood Absolute Lymphocyte/Monocyte Ratio at Diagnosis and during Treatment in Patients with Diffuse Large B-Cell Lymphoma

Infusion of NKp30/KIR2DL2 Natural Killer Cell Ratio and Survival Post-Autologous Stem Cell Transplantation in Lymphomas

Impact of MYD88 L265P mutation Status on Histological Transformation of Waldenstrom Macroglobulinemia

Autologous Stem Cell Transplantation for Mantle Cell Lymphoma in the Elderly (≥65 Years Of Age): The Mayo Clinic Experience

Baseline Immune Dysregulation in Autologous Stem Cell Transplant Recipients Is Associated with a 'Graft Versus Host'-like Syndrome and Results in Poor Outcomes

PD-1 Blockade with Pembrolizumab in Relapsed Low Grade Non-Hodgkin Lymphoma

Outcomes of DLBCL Patients Entering Surveillance (without maintenance) after Immunochemotherapy in a Large Observational Study

Treatment and Clinical Outcomes of High Grade B-Cell Lymphomas with MYC and BCL2 and/or BCL6 Rearrangements (Double Hit/Triple Hit Lymphomas)

Subnormal Lymphocyte Count Predicts Inferior Survival in Myelodysplastic Syndromes: A Single Center Experience in 889 Patients

Sustained Natural Killer Cell Recovery Post-Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation Predicts Survival in Non-Hodgkin's Lymphoma

Treatment Patterns and Outcomes of DLBCL after Failure of Front-Line Immunochemotherapy

Lymphocyte-to-Monocyte Ratio at Diagnosis and Survival in De Novo Double/Triple Hit Diffuse Large B-Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only